FDA Inspection
Neilmed Pharmaceuticals IncNeilmed Pharmaceuticals Inc – FDA Inspection, Jul 22, 2026
Record Details
This FDA Inspection record concerns Neilmed Pharmaceuticals Inc, with an inspection on July 22, 2026, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · ff66da1e-7d74-49da-91cf-fd53ed5d57f9
Inspection Facts
- Inspection number
- 1305568
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued, view the record
FDA Citations
6- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.84(d)(2)Establish reliability of supplier's C of A
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Neilmed Pharmaceuticals Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 2, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Neilmed Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.